Cite
The Use of Splenectomy to Manage Platelet Transfusion Refractoriness due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation.
MLA
Mauro, Margherita, et al. “The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation.” Pediatric Reports, vol. 8, no. 1, Mar. 2016, p. 6159. EBSCOhost, https://doi.org/10.4081/pr.2016.6159.
APA
Mauro, M., Camoglio, F., Piccoli, P., De Bortoli, M., Balter, R., Pegoraro, A., & Cesaro, S. (2016). The Use of Splenectomy to Manage Platelet Transfusion Refractoriness due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation. Pediatric Reports, 8(1), 6159. https://doi.org/10.4081/pr.2016.6159
Chicago
Mauro, Margherita, Francesco Camoglio, Pierluigi Piccoli, Massimiliano De Bortoli, Rita Balter, Anna Pegoraro, and Simone Cesaro. 2016. “The Use of Splenectomy to Manage Platelet Transfusion Refractoriness Due to Anti-Human Leukocyte Antibodies in Allogeneic Stem Cell Transplantation.” Pediatric Reports 8 (1): 6159. doi:10.4081/pr.2016.6159.